Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

C-Met-IN-11

C-Met-IN-11 (compound 3) is a potent c-MET and VEGFR-2 inhibitor, with IC50 values of 41.4 and 71.1 nM, respectively[1].

Product Specifications

CAS Number

1446324-05-5

UNSPSC

12352005

Target

C-Met/HGFR; VEGFR

Type

Reference compound

Related Pathways

Protein Tyrosine Kinase/RTK

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/c-met-in-11.html

Solubility

10 mM in DMSO

Smiles

COC1=CC2=NC=CC(OC3=C(C=C(C=C3)NC4=C5C(C(C6=CC=C(C=C6)F)=CNC5=CC=N4)=O)F)=C2C=C1

Molecular Formula

C30H20F2N4O3

Molecular Weight

522.50

References & Citations

[1]Xu H, et al. Discovery of N-substituted-3-phenyl-1,6-naphthyridinone derivatives bearing quinoline moiety as selective type II c-Met kinase inhibitors against VEGFR-2. Bioorg Med Chem. 2020 Jun 15;28 (12) :115555.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

VEGFR2/KDR/Flk-1

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

ATG4B Antibody: HRP
SPC-630D-HRP 100 µg

ATG4B Antibody: HRP

Sign In for Pricing
View Details
Human CD31 Recombinant Rabbit monoclonal Antibody
HA722908B 100 µL

Human CD31 Recombinant Rabbit monoclonal Antibody

Sign In for Pricing
View Details
alpha-Tocopherol-d6
TRC-T526127-1MG 1 mg

alpha-Tocopherol-d6

Sign In for Pricing
View Details
Myosin light chain 3 (MYL3) (NM_000258) Human Over-expression Lysate
LC400098 20 µg

Myosin light chain 3 (MYL3) (NM_000258) Human Over-expression Lysate

Sign In for Pricing
View Details
ACTR3C (NM_001164458) Human Over-expression Lysate
LC431172 20 µg

ACTR3C (NM_001164458) Human Over-expression Lysate

Sign In for Pricing
View Details
Human IL-1 alpha/IL1A, C-His, Flag Tag
HA210602-01 20 µg

Human IL-1 alpha/IL1A, C-His, Flag Tag

Sign In for Pricing
View Details